Non-Muscle Invasive Bladder Urothelial Carcinoma

Non-Muscle Invasive Bladder Urothelial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05483868	A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer	active not recruiting	Phase 1	55	Aura BiosciencesINDUSTRY	2	Aug 6, 2026	clinicaltrials
NCT05521698	A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer	recruiting	Phase 1	80	University of Wisconsin, MadisonOTHER	1	Jul 7, 2026	clinicaltrials